The Covid cash cow – a look at the Covid vaccine sales figures
pharmaphorum
NOVEMBER 19, 2021
Pfizer’s position will be further boosted with the recent green light for adolescents and 5–11 year olds, as well as the roll out of booster jabs. Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. Much of the market will depend on how boosters and variants might play out, but Breen believes Covid is a cash cow. “It
137 
Let's personalize your content